Table 4.

Adjusted and Unadjusted Outcomes According to Sex

30‐Day Outcomes	Overall STEMI (n=6330)	Female Patients (n=1315)	Male Patients (n=5015)	Unadjusted P Value	Odds Ratio	95% CI	Adjusted* P Value
MACE	615 (9.7)	158 (12.0)	457 (9.1)	0.002	1.2	0.96–1.50	0.11
All‐cause mortality	464 (7.3)	129 (9.8)	335 (6.7)	<0.001	1.38	1.06–1.79	0.02
MACCE	646 (10.2)	165 (12.5)	481 (9.6)	0.002	1.2	0.96–1.49	0.11
Major bleeding	158 (2.5)	50 (3.8)	108 (2.2)	<0.001	1.54	1.08–2.20	0.02
New heart failure	101 (1.6)	29 (2.2)	72 (1.4)	0.047	1.28	0.82–2.01	0.28
Recurrent MI	89 (1.4)	22 (1.7)	67 (1.3)	0.36	1.15	0.70–1.89	0.58
New renal impairment	394 (6.4)	103 (8.1)	291 (6.0)	0.005	1.12	0.88–1.44	0.36

Data are presented as number (percentage). MACCE indicates major cardiovascular and cerebrovascular events; MACE, major cardiovascular events; MI, myocardial infarction; and STEMI, ST‐segment–elevation myocardial infarction.

^*Adjustment was made for patient age, comorbidities, cardiogenic shock, intubation and out‐of‐hospital cardiac arrest, and time of symptom onset (day vs night).